Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Logo for

Mol. Cell. Biol. 21 (19): 6387-6394

Copyright © 2001 by the American Society for Microbiology. All rights reserved.

Molecular and Cellular Biology, October 2001, p. 6387-6394, Vol. 21, No. 19
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.19.6387-6394.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Receptor Heterodimerization: Essential Mechanism for Platelet-Derived Growth Factor-Induced Epidermal Growth Factor Receptor Transactivation

Yuji Saito, Judith Haendeler, Yukihiro Hojo, Kei Yamamoto, and Bradford C. Berk*

Center for Cardiovascular Research, University of Rochester, Rochester, New York

Received 18 April 2001/Returned for modification 29 May 2001/Accepted 18 June 2001

Previous studies showed that the epidermal growth factor receptor (EGFR) can be transactivated by platelet-derived growth factor (PDGF) stimulation and that EGFR transactivation is required for PDGF-stimulated cell migration. To investigate the mechanism for cross talk between the PDGF beta  receptor (PDGFbeta R) and the EGFR, we stimulated rat aortic vascular smooth muscle cells (VSMC) with 20 ng of PDGF/ml. Transactivation of the EGFR, defined by receptor tyrosine phosphorylation, occurred with the same time course as PDGFbeta R activation. Basal formation of PDGFbeta R-EGFR heterodimers was shown by coimmunoprecipitation studies, and interestingly, disruption of this receptor heterodimer abolished EGFR transactivation. Breakdown of the heterodimer was observed when VSMC were pretreated with antioxidants or with a Src family kinase inhibitor. Disruption of heterodimers decreased ERK1 and ERK2 activation by PDGF. Although PDGF-induced PDGFbeta R activation was abolished after pretreatment with 1 µM AG1295 (a specific PDGF receptor kinase inhibitor), EGFR transactivation was still observed, indicating that PDGFbeta R kinase activity is not required. In conclusion, our data demonstrate that the PDGFbeta R and the EGFR form PDGFbeta R-EGFR heterodimers basally, and we suggest that heterodimers represent a novel signaling complex which plays an important role in PDGF signal transduction.

* Corresponding author. Mailing address: Center for Cardiovascular Research, University of Rochester, 601 Elmwood Ave., Box 679, Rochester, NY 14642. Phone: (716) 273-1946. Fax: (716) 273-1497. E-mail: bradford_berk{at}urmc.rochester.edu.

Molecular and Cellular Biology, October 2001, p. 6387-6394, Vol. 21, No. 19
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.19.6387-6394.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Mast cell tryptase stimulates production of decorin by human testicular peritubular cells: possible role of decorin in male infertility by interfering with growth factor signaling.
M. Adam, J. U. Schwarzer, F. M. Kohn, L. Strauss, M. Poutanen, and A. Mayerhofer (2011)
Hum. Reprod. 26, 2613-2625
   Abstract »    Full Text »    PDF »
Myosin-II inhibition and soft 2D matrix maximize multinucleation and cellular projections typical of platelet-producing megakaryocytes.
J.-W. Shin, J. Swift, K. R. Spinler, and D. E. Discher (2011)
PNAS 108, 11458-11463
   Abstract »    Full Text »    PDF »
Thrombospondin-1 opens the paracellular pathway in pulmonary microvascular endothelia through EGFR/ErbB2 activation.
P. Garg, S. Yang, A. Liu, M. A. Pallero, D. J. Buchsbaum, D. F. Mosher, J. E. Murphy-Ullrich, and S. E. Goldblum (2011)
Am J Physiol Lung Cell Mol Physiol 301, L79-L90
   Abstract »    Full Text »    PDF »
PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas.
T. Ozawa, C. W. Brennan, L. Wang, M. Squatrito, T. Sasayama, M. Nakada, J. T. Huse, A. Pedraza, S. Utsuki, Y. Yasui, et al. (2010)
Genes & Dev. 24, 2205-2218
   Abstract »    Full Text »    PDF »
The {alpha}-Receptor for Platelet-Derived Growth Factor Confers Bone-Metastatic Potential to Prostate Cancer Cells by Ligand- and Dimerization-Independent Mechanisms.
M. R. Russell, Q. Liu, H. Lei, A. Kazlauskas, and A. Fatatis (2010)
Cancer Res. 70, 4195-4203
   Abstract »    Full Text »    PDF »
FRS2 via Fibroblast Growth Factor Receptor 1 Is Required for Platelet-derived Growth Factor Receptor {beta}-mediated Regulation of Vascular Smooth Muscle Marker Gene Expression.
P.-Y. Chen, M. Simons, and R. Friesel (2009)
J. Biol. Chem. 284, 15980-15992
   Abstract »    Full Text »    PDF »
Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor.
T. J. Abouantoun and T. J. MacDonald (2009)
Mol. Cancer Ther. 8, 1137-1147
   Abstract »    Full Text »    PDF »
RET/PTC-Induced Cell Growth Is Mediated in Part by Epidermal Growth Factor Receptor (EGFR) Activation: Evidence for Molecular and Functional Interactions between RET and EGFR.
M. Croyle, N. Akeno, J. A. Knauf, D. Fabbro, X. Chen, J. E. Baumgartner, H. A. Lane, and J. A. Fagin (2008)
Cancer Res. 68, 4183-4191
   Abstract »    Full Text »    PDF »
Transcription-Dependent Epidermal Growth Factor Receptor Activation by Hepatocyte Growth Factor.
T. E. Reznik, Y. Sang, Y. Ma, R. Abounader, E. M. Rosen, S. Xia, and J. Laterra (2008)
Mol. Cancer Res. 6, 139-150
   Abstract »    Full Text »    PDF »
Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells.
M. Hurtado, J. J. Lozano, E. Castellanos, L. A Lopez-Fernandez, K. Harshman, C. Martinez-A, A. R Ortiz, T. M Thomson, and R. Paciucci (2007)
Gut 56, 1266-1274
   Abstract »    Full Text »    PDF »
Sphingosine-1-Phosphate Stimulates the Functional Capacity of Progenitor Cells by Activation of the CXCR4-Dependent Signaling Pathway via the S1P3 Receptor.
D. H. Walter, U. Rochwalsky, J. Reinhold, F. Seeger, A. Aicher, C. Urbich, I. Spyridopoulos, J. Chun, V. Brinkmann, P. Keul, et al. (2007)
Arterioscler Thromb Vasc Biol 27, 275-282
   Abstract »    Full Text »    PDF »
Heterodimerization of FGF-receptor 1 and PDGF-receptor-{alpha}: a novel mechanism underlying the inhibitory effect of PDGF-BB on FGF-2 in human cells.
D. Faraone, M. S. Aguzzi, G. Ragone, K. Russo, M. C. Capogrossi, and A. Facchiano (2006)
Blood 107, 1896-1902
   Abstract »    Full Text »    PDF »
Morphoproteomic and Pharmacoproteomic Rationale for mTOR Effectors as Therapeutic Targets in Head and Neck Squamous Cell Carcinoma.
R. E. Brown, P. L. Zhang, M. Lun, S. Zhu, P. K. Pellitteri, A. Law, G. C. Wood, and T. L. Kennedy (2006)
Ann. Clin. Lab. Sci. 36, 273-282
   Abstract »    Full Text »    PDF »
Uncoupling between Epidermal Growth Factor Receptor and Downstream Signals Defines Resistance to the Antiproliferative Effect of Gefitinib in Bladder Cancer Cells.
W. Kassouf, C. P.N. Dinney, G. Brown, D. J. McConkey, A. J. Diehl, M. Bar-Eli, and L. Adam (2005)
Cancer Res. 65, 10524-10535
   Abstract »    Full Text »    PDF »
Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer: It's Time to Get Back on Target.
N. J. Meropol (2005)
J. Clin. Oncol. 23, 1791-1793
   Full Text »    PDF »
Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451.
W. G. Roberts, P. M. Whalen, E. Soderstrom, G. Moraski, J. P. Lyssikatos, H.-F. Wang, B. Cooper, D. A. Baker, D. Savage, D. Dalvie, et al. (2005)
Cancer Res. 65, 957-966
   Abstract »    Full Text »    PDF »
Vascular NADPH oxidases: molecular mechanisms of activation.
R. P. Brandes and J. Kreuzer (2005)
Cardiovasc Res 65, 16-27
   Abstract »    Full Text »    PDF »
Reactive Oxygen Species Mediate Met Receptor Transactivation by G Protein-coupled Receptors and the Epidermal Growth Factor Receptor in Human Carcinoma Cells.
O. M. Fischer, S. Giordano, P. M. Comoglio, and A. Ullrich (2004)
J. Biol. Chem. 279, 28970-28978
   Abstract »    Full Text »    PDF »
Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes.
F. Dandre and G. K. Owens (2004)
Am J Physiol Heart Circ Physiol 286, H2042-H2051
   Abstract »    Full Text »    PDF »
Sphingosine 1-Phosphate Transactivates the Platelet-Derived Growth Factor {beta} Receptor and Epidermal Growth Factor Receptor in Vascular Smooth Muscle Cells.
T. Tanimoto, A. O. Lungu, and B. C. Berk (2004)
Circ. Res. 94, 1050-1058
   Abstract »    Full Text »    PDF »
Dimerization of the scavenger receptor class B type I: formation, function, and localization in diverse cells and tissues.
E. Reaven, Y. Cortez, S. Leers-Sucheta, A. Nomoto, and S. Azhar (2004)
J. Lipid Res. 45, 513-528
   Abstract »    Full Text »    PDF »
Epidermal Growth Factor Receptor Transactivation Is Regulated by Glucose in Vascular Smooth Muscle Cells.
A. Konishi and B. C. Berk (2003)
J. Biol. Chem. 278, 35049-35056
   Abstract »    Full Text »    PDF »
Hrs regulates early endosome fusion by inhibiting formation of an endosomal SNARE complex.
W. Sun, Q. Yan, T. A. Vida, and A. J. Bean (2003)
J. Cell Biol. 162, 125-137
   Abstract »    Full Text »    PDF »
Efficacy and Toxicity of the Angiogenesis Inhibitor SU5416 As a Single Agent in Patients with Advanced Renal Cell Carcinoma, Melanoma, and Soft Tissue Sarcoma.
B. C. Kuenen, J. Tabernero, J. Baselga, F. Cavalli, E. Pfanner, P. F. Conte, S. Seeber, S. Madhusudan, G. Deplanque, H. Huisman, et al. (2003)
Clin. Cancer Res. 9, 1648-1655
   Abstract »    Full Text »    PDF »
Transactivation of gp130 in Myeloma Cells.
J. D. French, D. K. Walters, and D. F. Jelinek (2003)
J. Immunol. 170, 3717-3723
   Abstract »    Full Text »    PDF »
Cholesterol Depletion from the Plasma Membrane Triggers Ligand-independent Activation of the Epidermal Growth Factor Receptor.
X. Chen and M. D. Resh (2002)
J. Biol. Chem. 277, 49631-49637
   Abstract »    Full Text »    PDF »
Transactivation of Vascular Endothelial Growth Factor (VEGF) Receptor Flk-1/KDR Is Involved in Sphingosine 1-Phosphate-stimulated Phosphorylation of Akt and Endothelial Nitric-oxide Synthase (eNOS).
T. Tanimoto, Z.-G. Jin, and B. C. Berk (2002)
J. Biol. Chem. 277, 42997-43001
   Abstract »    Full Text »    PDF »
Protein Kinase C-alpha and Protein Kinase C-epsilon Are Required for Grb2-associated Binder-1 Tyrosine Phosphorylation in Response to Platelet-derived Growth Factor.
Y. Saito, Y. Hojo, T. Tanimoto, J.-i. Abe, and B. C. Berk (2002)
J. Biol. Chem. 277, 23216-23222
   Abstract »    Full Text »    PDF »
RYK, a Catalytically Inactive Receptor Tyrosine Kinase, Associates with EphB2 and EphB3 but Does Not Interact with AF-6.
E. Trivier and T. S. Ganesan (2002)
J. Biol. Chem. 277, 23037-23043
   Abstract »    Full Text »    PDF »
Platelet-derived Growth Factor (PDGF)-induced Tyrosine Phosphorylation of the Low Density Lipoprotein Receptor-related Protein (LRP). EVIDENCE FOR INTEGRATED CO-RECEPTOR FUNCTION BETWEEN LRP AND THE PDGF.
E. Loukinova, S. Ranganathan, S. Kuznetsov, N. Gorlatova, M. M. Migliorini, D. Loukinov, P. G. Ulery, I. Mikhailenko, D. A. Lawrence, and D. K. Strickland (2002)
J. Biol. Chem. 277, 15499-15506
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882